China National Accord Medicines Corporation Ltd. (SHE:000028)
China
· Delayed Price · Currency is CNY 24.80
+0.11 (0.45%)
Apr 29, 2026, 3:04 PM CST
SHE:000028 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 1,136 | 642.49 | 1,599 | 1,487 | 1,336 | Upgrade
|
| Depreciation & Amortization | - | 1,229 | 1,545 | 1,426 | 1,307 | 1,242 | Upgrade
|
| Other Amortization | - | 200.02 | 198.4 | 163.56 | 180.31 | 188.65 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -7.96 | -11.87 | -45.31 | -6.26 | -2.7 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 285.76 | 971.84 | 0.63 | 55.64 | 236.84 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -294.38 | -356.87 | -309.08 | -28.87 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | 83.95 | 94.15 | 71.36 | 29.77 | 44.22 | Upgrade
|
| Other Operating Activities | - | 197.59 | -119.54 | 630.83 | 357.4 | 131.94 | Upgrade
|
| Change in Accounts Receivable | - | -1,484 | -965.33 | -3,992 | 1,227 | -2,121 | Upgrade
|
| Change in Inventory | - | -721.59 | 559.6 | -170.13 | -217.84 | -1,260 | Upgrade
|
| Change in Accounts Payable | - | 1,309 | 463.05 | 3,688 | -1,949 | 2,135 | Upgrade
|
| Change in Other Net Operating Assets | - | -213.62 | 305.42 | -79.9 | 193.22 | -203.6 | Upgrade
|
| Operating Cash Flow | - | 1,639 | 3,271 | 2,937 | 2,560 | 1,655 | Upgrade
|
| Operating Cash Flow Growth | - | -49.91% | 11.38% | 14.71% | 54.69% | 10.14% | Upgrade
|
| Capital Expenditures | - | -217.35 | -282.7 | -322.21 | -322.19 | -370.43 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1.82 | 1.2 | 37.88 | 4.94 | 1.02 | Upgrade
|
| Cash Acquisitions | - | -7.42 | -71.4 | - | -126.35 | -109.95 | Upgrade
|
| Divestitures | - | - | - | 3.23 | - | - | Upgrade
|
| Investment in Securities | - | 20.94 | 6.58 | -3.72 | 89.66 | -144.03 | Upgrade
|
| Other Investing Activities | - | 99.09 | 195.63 | 149.38 | 11.12 | 167.86 | Upgrade
|
| Investing Cash Flow | - | -102.92 | -150.69 | -135.43 | -342.82 | -455.53 | Upgrade
|
| Short-Term Debt Issued | - | 1,672 | 1,560 | 1,873 | - | 81.45 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 4 | 1,520 | 932.68 | Upgrade
|
| Total Debt Issued | - | 1,672 | 1,560 | 1,877 | 1,520 | 1,014 | Upgrade
|
| Short-Term Debt Repaid | - | -1,531 | -1,575 | -2,363 | -72.45 | -65.7 | Upgrade
|
| Long-Term Debt Repaid | - | -1,026 | -1,224 | -1,272 | -2,629 | -2,100 | Upgrade
|
| Total Debt Repaid | - | -2,558 | -2,799 | -3,635 | -2,701 | -2,165 | Upgrade
|
| Net Debt Issued (Repaid) | - | -885.17 | -1,239 | -1,758 | -1,181 | -1,151 | Upgrade
|
| Issuance of Common Stock | - | - | - | 31.6 | - | - | Upgrade
|
| Common Dividends Paid | - | -386.29 | -603.77 | -559.07 | -574.19 | -610.54 | Upgrade
|
| Other Financing Activities | - | -90.76 | 11.29 | -121.87 | 247.65 | -109.86 | Upgrade
|
| Financing Cash Flow | - | -1,362 | -1,831 | -2,408 | -1,508 | -1,872 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.07 | -1.2 | -0.94 | -1.19 | 0.39 | Upgrade
|
| Net Cash Flow | - | 173.36 | 1,288 | 393.12 | 708.66 | -671.6 | Upgrade
|
| Free Cash Flow | - | 1,421 | 2,989 | 2,615 | 2,238 | 1,285 | Upgrade
|
| Free Cash Flow Growth | - | -52.45% | 14.30% | 16.83% | 74.22% | 6.27% | Upgrade
|
| Free Cash Flow Margin | - | 1.94% | 4.02% | 3.46% | 3.05% | 1.88% | Upgrade
|
| Free Cash Flow Per Share | - | 2.55 | 5.35 | 4.69 | 4.02 | 2.31 | Upgrade
|
| Cash Income Tax Paid | - | 1,736 | 1,771 | 1,887 | 1,782 | 1,564 | Upgrade
|
| Levered Free Cash Flow | - | 2,014 | 1,992 | 877.02 | 2,410 | 135.8 | Upgrade
|
| Unlevered Free Cash Flow | - | 2,135 | 2,154 | 1,032 | 2,573 | 315.83 | Upgrade
|
| Change in Working Capital | - | -1,192 | 307.52 | -599.77 | -821.69 | -1,523 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.